首页> 外文期刊>European Journal of Medicinal Plants >Effect of Acute Administration of Aqueous Leaf Extract of Moringa oleifera on Immunoglobulin levels in Wistar Rats
【24h】

Effect of Acute Administration of Aqueous Leaf Extract of Moringa oleifera on Immunoglobulin levels in Wistar Rats

机译:辣木水提取物急性给药对Wistar大鼠免疫球蛋白水平的影响

获取原文
           

摘要

Aims: This present study aims to determine the effect of acute administration of aqueous extract of Moringa oleifera leaf on immunoglobulins in wistar rats. Methods: Acute toxicity study of aqueous Moringa oleifera leaf extract was done using 24 mice divided into six (6) groups of four (4) were used. The graded doses of the extract (0.2, 0.5, 1.0, 1.5 and 2.0 i.p) corresponding to group 2, 3, 4, 5, and 6 served as test groups; group 1 received distilled water as control. Forty (40) male rats were randomly divided into 5 groups of 8 rats each. Group 1 served as control and received distilled water, while groups 2, 3, 4 and 5 served as test groups and received 20 mg/kg bw, 40 mg/kg bw, 60 mg/kg bw and 80 mg/kg bw of the extract respectively. The administration was for 14 days. At the end of administration, blood samples were collected by cardiac puncture and IgA, IgG and IgM levels were estimated by the immunoturbudrimetric method. Data were subjected to statistical analysis. A p value less than 0.05 was considered significant. Results: The acute toxicity study showed LD50 of 1 g/kg. Result obtained show a significant (p<0.05) reduction in the serum concentration of immunoglobulin G (IgG); and a significant (p<0.05) increase in the serum levels of immunoglobulins A and M (IgA and IgM) at a dose of 40 mg/kg of the extract. However, a significant (p<0.05) increase was observed for immunoglobulin A at 60 mg/kg when compared to the control. There were no significant changes in the immunoglobulins at the other concentrations. Conclusion: The present study demonstrates possible beneficial therapeutic effect on the amelioration of immunological diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis, psoriasis etc in human clinical trials, especially at low concentration for immunoglobulins A and M. This finding supports the anecdotal use of leaf extracts of Moringa oleifera as an immune boosting agent.
机译:目的:本研究旨在确定辣木叶片水提取物急性给药对wistar大鼠免疫球蛋白的影响。方法:用24只小鼠分成六(6)组,每组四(4)只,进行辣木叶提取物的急性毒性研究。对应于第2、3、4、5和6组的提取物的分级剂量(0.2、0.5、1.0、1.5和2.0 i.p)作为测试组;第1组接受蒸馏水作为对照。将四十(40)只雄性大鼠随机分为5组,每组8只。第1组作为对照组并接受蒸馏水,而第2、3、4和5组作为试验组并接受20 mg / kg体重,40 mg / kg体重,60 mg / kg体重和80 mg / kg体重的分别提取。给药持续14天。在给药结束时,通过心脏穿刺收集血液样品,并通过免疫比浊法估计IgA,IgG和IgM水平。对数据进行统计分析。 P值小于0.05被认为是显着的。结果:急性毒性研究显示LD 50 为1 g / kg。获得的结果显示,血清免疫球蛋白G(IgG)浓度显着降低(p <0.05);剂量为40 mg / kg提取物时,免疫球蛋白A和M(IgA和IgM)的血清水平显着(p <0.05)增加。但是,与对照组相比,免疫球蛋白A在60 mg / kg时显着增加(p <0.05)。其他浓度的免疫球蛋白无明显变化。结论:本研究表明,在人类临床试验中,特别是在低浓度的免疫球蛋白A和M时,对改善系统性红斑狼疮(SLE),类风湿性关节炎,牛皮癣等免疫性疾病可能具有有益的治疗作用。辣木叶提取物作为免疫增强剂的用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号